Campo DC | Valor | Idioma |
dc.contributor.author | AGARWAL, NEERAJ | - |
dc.contributor.author | AZAD, ARUN | - |
dc.contributor.author | SHORE, NEAL D | - |
dc.contributor.author | CARLES, JOAN | - |
dc.contributor.author | André Poisl Fay | - |
dc.contributor.author | DUNSHEE, CURTIS | - |
dc.contributor.author | KARSH, LAWRENCE IVAN | - |
dc.contributor.author | PACCAGNELLA, MARIA LUISA | - |
dc.contributor.author | SANTO, NICOLA DI | - |
dc.contributor.author | ELMELIEGY, MOHAMED | - |
dc.contributor.author | LIN, XUN | - |
dc.contributor.author | CZIBERE, AKOS | - |
dc.contributor.author | FIZAZI, KARIM | - |
dc.date.accessioned | 2023-03-29T18:12:59Z | - |
dc.date.available | 2023-03-29T18:12:59Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1479-6694 | - |
dc.identifier.uri | https://hdl.handle.net/10923/23944 | - |
dc.language.iso | en | - |
dc.relation.ispartof | Future Oncology | - |
dc.rights | openAccess | - |
dc.title | Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design | - |
dc.type | Article | - |
dc.date.updated | 2023-03-29T18:12:58Z | - |
dc.identifier.doi | DOI:10.2217/fon-2021-0811 | - |
dc.jtitle | Future Oncology | - |
dc.volume | 18 | - |
dc.issue | 4 | - |
dc.spage | 425 | - |
dc.epage | 436 | - |
Aparece en las colecciones: | Artigo de Periódico
|